BRD4 and neoplasm: Surprisingly, using the TCGA transcriptomic data we did not observe a significant association of BRD4 expression with cancer stemness across 27 tested tumor types, in contrast to previously reported TRIM28 and newly discovered ATAD2 (and to some part also SMARCA4) and cancer de‐differentiation status.